Cannara Declares Issuance of Options and Restricted Stock Units

Company Overview

• Cannara Biotech Inc.: A vertically integrated producer of premium-grade cannabis products, Cannara operates two large facilities in Québec, covering over 1,650,000 square feet. The company focuses on providing affordable cannabis products, leveraging low electricity costs in the region.

Recent Developments

• Incentive Awards Approved: The board of directors has approved the grant of incentive awards under the Company’s stock option plan and restricted share unit compensation plan, aligning with the completion of the fiscal year on August 31, 2025.
• Stock Options Granted: A total of 3,625,000 stock options were granted to employees, each exercisable into one common share at an exercise price of $1.44. These options will vest monthly over three years and expire ten years from the grant date.
• Restricted Share Units: Additionally, 145,000 restricted share units (RSUs) were granted to board members, vesting fully on the second anniversary of the grant date.

Financial Performance

• Year-over-Year Growth: The announcement coincides with Cannara's five consecutive years of commercial operations and consistent year-over-year revenue growth since the launch of its cannabis business.

Contact Information

• Key Contacts: For further inquiries, Nicholas Sosiak (CFO) and Zohar Krivorot (President & CEO) are available via their respective emails.

Regulatory Note

• TSX Venture Exchange: The release clarifies that neither the TSX Venture Exchange nor its Regulation Services Provider is responsible for the adequacy or accuracy of the information provided.